7RA Stock Overview Provides behavioral healthcare services in the United States and Puerto Rico. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Acadia Healthcare Company, Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Acadia Healthcare Company Historical stock prices Current Share Price US$40.60 52 Week High US$80.50 52 Week Low US$34.20 Beta 1.29 1 Month Change 10.33% 3 Month Change -14.35% 1 Year Change -47.95% 3 Year Change -13.25% 5 Year Change 37.16% Change since IPO 16.69%
Recent News & Updates
Saxena White P.A. Files Securities Fraud Class Action Against Acadia Healthcare Company, Inc Dec 12
Investor sentiment deteriorates as stock falls 18% Nov 06
Acadia Healthcare Company, Inc. Revises Earnings Guidance for the Year 2024 Nov 02
Third quarter 2024 earnings released: EPS: US$0.74 (vs US$2.39 loss in 3Q 2023) Nov 01
Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Files Against Acadia Healthcare Company, Inc Oct 25
Robbins Geller Rudman & Dowd LLP Announces Class Action Lawsuit Against Acadia Healthcare Company, Inc Oct 17 See more updates
Saxena White P.A. Files Securities Fraud Class Action Against Acadia Healthcare Company, Inc Dec 12
Investor sentiment deteriorates as stock falls 18% Nov 06
Acadia Healthcare Company, Inc. Revises Earnings Guidance for the Year 2024 Nov 02
Third quarter 2024 earnings released: EPS: US$0.74 (vs US$2.39 loss in 3Q 2023) Nov 01
Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Files Against Acadia Healthcare Company, Inc Oct 25
Robbins Geller Rudman & Dowd LLP Announces Class Action Lawsuit Against Acadia Healthcare Company, Inc Oct 17
Acadia Healthcare Company, Inc. to Report Q3, 2024 Results on Oct 30, 2024 Oct 10
New minor risk - Share price stability Oct 01
New minor risk - Share price stability Aug 02
Acadia Healthcare Company, Inc. Announces Impairment Charges for Three Months Ended June 30, 2024 Aug 02 Acadia Healthcare Company, Inc. Announces Impairment Charges for Three Months Ended June 30, 2024
Acadia Healthcare Company, Inc. to Report Q2, 2024 Results on Jul 31, 2024 Jul 16
Acadia Healthcare Company, Inc. Announces Executive Changes May 25
Acadia Healthcare Company, Inc. Affirms Earnings Guidance for the Year 2024 May 03
First quarter 2024 earnings released: EPS: US$0.84 (vs US$0.73 in 1Q 2023) May 02
Acadia Healthcare Company, Inc., Annual General Meeting, May 23, 2024 Apr 10 Acadia Healthcare Company, Inc. to Report Q1, 2024 Results on May 01, 2024
Acadia Healthcare Company, Inc. (NasdaqGS:ACHC) acquired Comprehensive Treatment Center in Greenville, North Carolina. Mar 29
Acadia Healthcare Company, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024 Feb 29
Full year 2023 earnings released: US$0.24 loss per share (vs US$3.05 profit in FY 2022) Feb 28
Acadia Healthcare Company, Inc. to Report Q4, 2023 Results on Feb 28, 2024 Feb 08
Director recently sold €3.1m worth of stock Dec 17
Executive Vice President of Operations recently sold €2.2m worth of stock Nov 14
Acadia Healthcare Company, Inc. Provides Revenue Guidance for the Year 2023 Nov 03
Third quarter 2023 earnings released: US$2.39 loss per share (vs US$0.79 profit in 3Q 2022) Nov 03
Acadia Healthcare Company, Inc. to Report Q3, 2023 Results on Nov 02, 2023 Oct 28
Acadia Healthcare Company, Inc. Appoints Dr. Patrice A. Harris as Independent Director Oct 27 Acadia Healthcare Company, Inc. and Youth and Family Centered Services of New Mexico Provide Update on Civil Litigation in New Mexico State District Court Oct 12
Washington State Department Of Social And Health Services acquired Cascade Behavioral Health Hospital from Acadia Healthcare Company, Inc. (NasdaqGS:ACHC) for $29.95 million. Aug 09 Acadia Healthcare Company, Inc. Revises Earnings Guidance for the Year 2023
Second quarter 2023 earnings released: EPS: US$0.79 (vs US$0.89 in 2Q 2022) Jul 28
Acadia Healthcare Company, Inc. to Report Q2, 2023 Results on Jul 27, 2023 Jul 07
Acadia Healthcare Company, Inc. Announces Executive Changes Jul 06 Acadia Healthcare Company, Inc. Announces Executive Changes
Acadia Healthcare Company, Inc. Names Judith Scimone as Chief Human Resources Officer May 17
First quarter 2023 earnings released: EPS: US$0.73 (vs US$0.68 in 1Q 2022) Apr 28
Full year 2022 earnings released: EPS: US$3.05 (vs US$2.29 in FY 2021) Mar 01
Acadia Healthcare Company, Inc. to Report Q4, 2022 Results on Feb 27, 2023 Feb 14
Acadia Healthcare Company, Inc. Names Laura Groschen as New Chief Information Officer Jan 04
Acadia Healthcare Company, Inc. (NasdaqGS:ACHC) acquired Four Comprehensive Treatment Centers of Brand New Start Treatment Centers from Brand New Start Treatment Centers. Nov 09
Third quarter 2022 earnings released: EPS: US$0.79 (vs US$0.74 in 3Q 2021) Nov 02
Acadia Healthcare Company, Inc. Narrows Revenue Guidance for the Year 2022 Nov 01
Acadia Healthcare Company, Inc. to Report Q3, 2022 Results on Oct 31, 2022 Oct 12 Acadia Healthcare Appoints Nasser Khan to Lead Its CTC Business
Seelos Therapeutics Announces the Participation of Acadia Healthcare in the Registration Directed Study of SLS-002 for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder Sep 14
Independent Director recently sold €415k worth of stock Sep 10
Chief Financial Officer recently sold €2.1m worth of stock Aug 09
Independent Director recently sold €491k worth of stock Aug 03
Second quarter 2022 earnings released: EPS: US$0.89 (vs US$0.50 in 2Q 2021) Jul 28
Acadia Healthcare Company, Inc. Provides Earnings Guidance for the Year 2022 Jul 28
Acadia Healthcare Company, Inc. to Report Q2, 2022 Results on Jul 27, 2022 Jul 14
Acadia Healthcare Company, Inc. Appoints R. David Kelly as Independent Director Jun 29
Acadia Healthcare Company, Inc. Announces Reeve B. Waud Resigns Effective Immediately from Each of the Audit and Risk Committee and Nominating and Governance Committee of the Board of Directors May 19
Acadia Healthcare Company, Inc. Provides Revenue Guidance for the Full Year 2022 May 05
First quarter 2022 earnings released: EPS: US$0.68 (vs US$0.25 in 1Q 2021) May 04
Acadia Healthcare Company, Inc. to Report Q1, 2022 Results on May 03, 2022 Apr 19
Acadia Healthcare Company, Inc., Annual General Meeting, May 19, 2022 Apr 09 Acadia Healthcare Announces Christopher Hunter as Director
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Mar 02
Acadia Healthcare Company, Inc. Provides Revenue Guidance for the First Quarter End Full Year 2022 Mar 02
Acadia Healthcare Company, Inc. to Report Q4, 2021 Results on Feb 28, 2022 Feb 17
Acadia Healthcare Company, Inc. Announces Retirement of Debbie Osteen as Chief Executive Officer Feb 02
Acadia Healthcare Company, Inc. (NasdaqGS:ACHC) acquired CenterPointe Behavioral Health System LLC. Jan 04
Acadia Healthcare Company, Inc. (NasdaqGS:ACHC) acquired three non-operational facilities located in Chicago. Dec 22
Third quarter 2021 earnings released: EPS US$0.74 (vs US$0.42 in 3Q 2020) Oct 29
Acadia Healthcare Company, Inc. Provides Earnings Guidance for 2021 Aug 04
Second quarter 2021 earnings released: EPS US$0.001 (vs US$0.47 in 2Q 2020) Aug 03
Executive Vice President of Operations recently sold €273k worth of stock Jun 17
First quarter 2021 earnings released: EPS US$0.25 (vs US$0.38 in 1Q 2020) May 01
Acadia Healthcare Company, Inc. Provides Revenue Guidance for the Year 2021 Apr 30
Independent Director recently sold €201k worth of stock Mar 17
New 90-day high: €46.40 Mar 02
Full year 2020 earnings released: EPS US$1.60 (vs US$1.24 in FY 2019) Feb 28
Acadia Healthcare Company, Inc. to Report Q4, 2020 Results on Feb 25, 2021 Feb 11 Acadia Healthcare Company, Inc. (NasdaqGS:ACHC) has signed a definitive agreement to acquire Vallejo behavioral health services of Adventist Health from Adventist Health Vallejo.
New 90-day high: €44.00 Feb 03
Waterland Private Equity Fund VII, fund managed by Waterland Private Equity Investments BV agreed to acquire Priory Group Limited from Acadia Healthcare Company, Inc. (NasdaqGS:ACHC) for £1.1 billion. Jan 09
New 90-day high: €41.80 Jan 05
Henry Ford Health System Partners with Acadia Healthcare Company, Inc Dec 12
Acadia Healthcare Company, Inc. Appoints Michael J. Fucci as Class III Director Oct 29
Acadia Healthcare Company, Inc. to Report Q3, 2020 Results on Oct 29, 2020 Oct 18
Acadia Healthcare Company, Inc. Provides an Update on the U.K. Sale Process Sep 30
Acadia Healthcare Company, Inc. to Report Q2, 2020 Results on Aug 04, 2020 Jul 22 Shareholder Returns 7RA DE Healthcare DE Market 7D -6.9% 2.4% 2.6% 1Y -47.9% 32.4% 13.4%
See full shareholder returns
Return vs Market: 7RA underperformed the German Market which returned 13.4% over the past year.
Price Volatility Is 7RA's price volatile compared to industry and market? 7RA volatility 7RA Average Weekly Movement 8.0% Healthcare Industry Average Movement 4.8% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.5% 10% least volatile stocks in DE Market 2.4%
Stable Share Price: 7RA's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 7RA's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities. Acadia Healthcare Company, Inc. was founded in 2005 and is headquartered in Franklin, Tennessee.
Show more Acadia Healthcare Company, Inc. Fundamentals Summary How do Acadia Healthcare Company's earnings and revenue compare to its market cap? 7RA fundamental statistics Market cap €3.96b Earnings (TTM ) €273.17m Revenue (TTM ) €3.04b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 7RA income statement (TTM ) Revenue US$3.12b Cost of Revenue US$1.78b Gross Profit US$1.35b Other Expenses US$1.07b Earnings US$280.73m
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/19 20:51 End of Day Share Price 2025/01/17 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Acadia Healthcare Company, Inc. is covered by 27 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Matthew Gillmor Baird Ishan Majumdar Baptista Research Sarah James Barclays
Show 24 more analysts 
